<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) generally has not collected <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific variables </plain></SENT>
<SENT sid="1" pm="."><plain>Because increasing numbers of studies are using ACS NSQIP data to study <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surgery, the objectives of the current study were 1) to examine differences between existing ACS NSQIP variables and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registry variables, and 2) to determine whether the addition of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific variables improves modeling of short-term outcomes </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Data from patients in the ACS NSQIP and National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Data Base (NCDB) who underwent colorectal resection for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were linked (2006-2008) </plain></SENT>
<SENT sid="3" pm="."><plain>By using regression methods, the relative importance of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> staging and neoadjuvant therapy variables were assessed along with their effects on morbidity, serious morbidity, and mortality </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: From 146 hospitals, 11,405 patients were identified who underwent surgery for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (colon, 85%; rectum, 15%) </plain></SENT>
<SENT sid="5" pm="."><plain>The NCDB <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic cancer</z:e> variable and the ACS NSQIP <z:e sem="disease" ids="C0346957" disease_type="Neoplastic Process" abbrv="">disseminated cancer</z:e> variables agreed marginally (Cohen kappa coefficient, 0.454) </plain></SENT>
<SENT sid="6" pm="."><plain>For mortality, only the ACS NSQIP <z:e sem="disease" ids="C0346957" disease_type="Neoplastic Process" abbrv="">disseminated cancer</z:e> variable and the NCDB stage IV variable were identified as important predictors; whereas the variables stage I through III, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (T)-classification, and lymph node (N)-classification were not selected </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> stage variables were inconsistently important for serious morbidity (stage IV, T-classification), superficial surgical site <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> (N-classification), venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> (<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic cancer</z:e>), and <z:hpo ids='HP_0002090'>pneumonia</z:hpo> (T-classification) </plain></SENT>
<SENT sid="8" pm="."><plain>With respect to neoadjuvant therapy, ACS NSQIP and NCDB variables agreed moderately (kappa, 0.570) and predicted superficial surgical site <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, serious morbidity, and organ space surgical site <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The model fit was similar regardless of the inclusion of stage and neoadjuvant therapy variables </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Although advanced disease stage and neoadjuvant therapy variables were predictors of short-term outcomes, their inclusion did not improve the models </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> 2013. Â© 2012 American <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Society </plain></SENT>
</text></document>